Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
09/06/2001 | US20010019718 Use of polymers as film-forming barrier materials |
09/06/2001 | US20010019715 Administering a cytotoxic T-lymphocyte and one agent capable of neutralizing or down regulating the activity of tumor secreted immunosuppressive factors |
09/06/2001 | US20010019712 Interferon and one fatty acid moiety covalently attached to the cytokine that enhances cutaneous delivery; treating infections or enhancing an immune response |
09/06/2001 | US20010018916 Process and device for inhalation of particulate medicaments |
09/06/2001 | DE19962251A1 Lozenge with thermally neutral dissolution properties containing active substance with exothermic dissolution behavior and compensatory adjuvant with endothermic dissolution behavior |
09/06/2001 | DE10009423A1 Cosmetic or pharmaceutical preparation especially for treatment of cellulite comprises nerve fibre stimulator or depolariser, phosphodiesterase inhibitor and antiestrogen |
09/06/2001 | DE10008307A1 Micro- and nano-capsules with cationic charges on surface are used in laundry and other detergents, skin cleansers, shampoos and skin and hair cosmetics |
09/06/2001 | DE10007816A1 Verfahren zur Herstellung von Nanosuspensionen A process for the preparation of nanosuspensions |
09/05/2001 | EP1130037A1 Process for obtaining polymers derived from vinyl acetate, and uses thereof |
09/05/2001 | EP1129771A1 Microcapsules |
09/05/2001 | EP1129724A2 Vaccines for treating colon cancer |
09/05/2001 | EP1129723A1 Combined vaccine against both hav and measle virus and method of producing it |
09/05/2001 | EP1129720A2 Stabilized granulocyte colony stimulating factor |
09/05/2001 | EP1129713A1 Veterinary compositions for the treatment of parasitic diseases |
09/05/2001 | EP1129709A2 Pharmaceutical composition based on ibuprofen and a procedure for the preparation thereof |
09/05/2001 | EP1129705A1 Powder formulation for inhalation |
09/05/2001 | EP1129704A1 Process for targeted administration of active agents on the central nervous system |
09/05/2001 | EP1129700A2 Composite structure with an adhesive matrix containing one or more active substances |
09/05/2001 | EP1129694A1 Use of components for modifying physico-chemical properties of the skin and/or the mucosal tissue as adhesion prevention/decreasing adhesion agents for microorganisms |
09/05/2001 | EP1129209A2 Polymer grafting by polysaccharide synthases |
09/05/2001 | EP1129201A1 Lysozyme fusion proteins in infections |
09/05/2001 | EP1129094A2 Therapeutic polymorphs of a gaba-a alpha-5 inverse agonist and pamoate formulations of the same |
09/05/2001 | EP1129079A2 2,4-disubstituded triazine derivatives with anti hiv activity |
09/05/2001 | EP1129064A1 Transfection reagents |
09/05/2001 | EP1128835A1 Cyanocobalamin (vitamin b 12?) treatment in allergic disease |
09/05/2001 | EP1128831A1 Pharmaceutical moxifloxacin preparation |
09/05/2001 | EP1128827A1 Pharmaceutical composition for modified release insulin sensitiser |
09/05/2001 | EP1128826A1 Chromone enteric release formulation |
09/05/2001 | EP1128824A1 Ionic silver complex |
09/05/2001 | EP1128821A1 A capsule based drug delivery system |
09/05/2001 | EP1128820A1 Pharmaceutical mixture comprising a combination of a profen and other active compounds |
09/05/2001 | EP1128819A1 New controlled release bead, a method of producing the same and multiple unit formulation comprising it |
09/05/2001 | EP1128818A1 Functionalized nanocrystals and their use in detection systems |
09/05/2001 | EP1128817A1 Microparticles containing peg and/or peg glyceryl esters |
09/05/2001 | EP1128816A1 Polyvinyl alcohol microspheres, and methods for making and therapeutic uses of the same |
09/05/2001 | EP1128815A1 Process for preparing oral calcium compositions |
09/05/2001 | EP1128814A1 Aerosols comprising nanoparticle drugs |
09/05/2001 | EP1128813A1 An inhalation system |
09/05/2001 | EP1128812A1 Nano-emulsion of 5-aminolevulinic acid |
09/05/2001 | EP1128811A1 Drug delivery device, especially for the delivery of progestins and estrogens |
09/05/2001 | EP1128810A1 Drug delivery device, especially for the delivery of androgens |
09/05/2001 | EP1128809A1 Aqueous ophthalmic formulations comprising chitosan |
09/05/2001 | EP1128800A1 Flavour blend for masking unpleasant taste of zinc compounds |
09/05/2001 | EP1128731A1 Compositions of restricted cells capable of rapid growth which produce proliferation suppressive materials, and uses thereof |
09/05/2001 | EP1128730A1 Antimicrobial composition comprising an oxidoreductase and an enhancing agent of the n-hydroxyanilide-type |
09/05/2001 | EP1128725A1 Disposable premoistened wipe containing an antimicrobial protease inhibitor |
09/05/2001 | EP0879249B1 Modified inulin |
09/05/2001 | EP0804162B1 Butylene oxide-ethylene oxide block copolymer surfactants as stabilizer coatings for nanocrystal formulation |
09/05/2001 | EP0760677B1 A pharmaceutical preparation comprising glucagon |
09/05/2001 | EP0746334B1 Pharmaceutical preparation containing plasminogen activators |
09/05/2001 | EP0744938B1 Liquid ophthalmic sustained release delivery system |
09/05/2001 | EP0642326B1 Non-fibrogenic, alginate-coated transplants, process of manufacture and method of use thereof |
09/05/2001 | CN1311798A Method for producing powder-shaped cross-linked polymerizates |
09/05/2001 | CN1311686A Pulmonary delivery of active agents |
09/05/2001 | CN1311674A Antioxidant, antiproliferous compositions, comprising a carnitine and a cerotenoid |
09/05/2001 | CN1311672A Pharmaceutical composition for injection based on paracetamol |
09/05/2001 | CN1311669A Orally disintegrable tablet |
09/05/2001 | CN1311668A Two-piece capsule for receiving pharmaceutical prepns. for powder inhalers |
09/05/2001 | CN1311667A Prepn. capable of releasing drug at target side in intestine |
09/05/2001 | CN1311666A Thermoprotected microparticle compositions and process for terminal steam sterilization thereof |
09/05/2001 | CN1311658A Dentifrice composition contg. encapsulated reactive ingredients |
09/05/2001 | CN1311649A Silk clothes for protecting affected parts |
09/05/2001 | CN1311644A Apparatus and method for providing a conscious patient relief from pain and anxiety associated with medical or surgical procedures |
09/05/2001 | CN1311257A Double specific monoclonal anti-body, its preparing method and thromobolysin made therefrom |
09/05/2001 | CN1311189A Synthesis of poly glycol monomethyl ether cholesterol succinate derivative and its preparation |
09/05/2001 | CN1311186A Deuteroporphyvin derivative, its preparing method and freeze dried preparation for injection |
09/05/2001 | CN1311018A Chinese herbal plaster for anti-cancer and analgesic |
09/05/2001 | CN1311012A Preparing method for auxiliary feedback treatment of disease medicine |
09/05/2001 | CN1311010A Smoke inhaling article for medical use, and its mfg. method |
09/05/2001 | CN1311008A Chinese angelica root oil soft capsule and its preparing process |
09/05/2001 | CN1311000A Mifepristone capsule and its preparing method |
09/05/2001 | CN1070377C Notoginseng medicinal oral liquid |
09/05/2001 | CN1070376C External use medicinal liquor for treating acute moist wart and prepn. method therefor |
09/05/2001 | CN1070374C Traditional Chinese medicinal prepn. for treating various kinds of pustule, lump and ulceration |
09/05/2001 | CN1070372C Powerful anti-cancer plaster and its prepn. method |
09/05/2001 | CN1070370C Crystalline amifostine compositions and process for prepn. of same and use thereof |
09/05/2001 | CN1070367C Injection adhesion and method for preparing same |
09/05/2001 | CN1070364C Cosmetic or skin-care composition of emulsion of oil covered with water formed with oil drops covered with liquid |
09/04/2001 | US6284941 Bandage having a scar treatment pad for scar management and scar repair |
09/04/2001 | US6284862 Monomers derived from hydroxy acids and polymers prepared therefrom |
09/04/2001 | US6284805 Aqueous solution of an acid addition salt of a 1-alkyl-n-(2,6-dimethylphenyl)-2-piperidinecaboxamide, wherein the solution is buffered. |
09/04/2001 | US6284804 Intended for application to the eye, ear or nose |
09/04/2001 | US6284803 Copolymerized units a) 15-83% by weight of at least one n-vinyllactam, b) 15-83% by weight of methyl methacrylate, c) 2-70% by weight of at least one other monomer |
09/04/2001 | US6284797 Capsaicin; norepinephrine inhibitor and a vasodilator which act to promote blood circulation in the treatment area |
09/04/2001 | US6284792 Formulation of valnemulin |
09/04/2001 | US6284765 (+) naloxone and epinephrine combination therapy |
09/04/2001 | US6284745 Gel compositions |
09/04/2001 | US6284744 Mixture of drug and hyaluronic acid; abdomen surgery |
09/04/2001 | US6284741 Genetic engineered nucleic acid |
09/04/2001 | US6284738 Injectable ready-to-use solutions containing an antitumor anthracycline glycoside |
09/04/2001 | US6284725 Administering binding compound for glucagon receptor such asglucagon-like peptide |
09/04/2001 | US6284452 Administering aqueous solution containing potassium, magnesium, sodium, calcium, chloride, oncotic agent, carboxylic acid or salt, sugar and clotting factor |
09/04/2001 | US6284375 Useful in variety of biomedical applications including drug delivery, vaccine targeting, drug distribution and uptake, membrane protein reconstitution, enzyme immobilization and construction of artificial cells such as blood cells |
09/04/2001 | US6284305 Applying undercoat comprising polymeric material and biologically active material to stent portion; applying discontinuous topcoat which covers less than entire surface of undercoat, topcoat comprising nonporous polymeric material |
09/04/2001 | US6284287 For administering drugs by breathing |
09/04/2001 | US6284283 Method of producing sub-micron particles of biologically active agents and uses thereof |
09/04/2001 | US6284282 Method of spray freeze drying proteins for pharmaceutical administration |
09/04/2001 | US6284280 Microparticles containing active ingredients, agents containing these microparticles, their use for ultrasound-controlled release of active ingredients, as well as a process for their production |
09/04/2001 | US6284277 Stable freeze-dried pharmaceutical formulation |
09/04/2001 | US6284276 Soluble form osmotic dose delivery system |